Injectable opportunities for CMOs despite internal capacity of big pharma sponsors
Pharmaceutical Technology
AUGUST 16, 2022
Large (market cap $10–100bn) and mega-cap (market cap >$100bn) sponsors also require contract manufacturers and packagers with specialist injectable capabilities in the case of cell and gene therapies, as shown in the report titled Contract Injectable Packaging Trends in the Bio/Pharma Industry (August 2022).
Let's personalize your content